Sharing our study in Diabetologia: In newly diagnosed T2D, earlier vs later glycaemic control was linked to lower cancer risk, despite similar cumulative glycaemic burden. Deeply grateful to my PhD mentors @Andrea_OY_Luk and @DrRonaldMa1 for their invaluable guidance and support.
New study reveals early #glycaemic management is key in #Type2Diabetes. Achieving lower HbA1c levels earlier vs later after diagnosis was linked to a lower long-term risk of #cancer, even if overall glucose burden was similar https://t.co/Vn90UwnRAu 🔓 #DiabetesResearch
On the cover, a new analysis of the SELECT trial confirms semaglutide lowers the risk of major heart problems in people who are overweight or obese and already have heart disease, even if they don’t have diabetes. 🫀
Read this & more in our new issue: https://t.co/SKYSq3IEoq